294 related articles for article (PubMed ID: 33853575)
21. "I think everybody should take it if they're doing drugs, doing heroin, or having sex for money": a qualitative study exploring perceptions of pre-exposure prophylaxis among female participants in an opioid intervention court program.
Przybyla SM; Cerulli C; Bleasdale J; Wilson K; Hordes M; El-Bassel N; Morse DS
Subst Abuse Treat Prev Policy; 2020 Nov; 15(1):89. PubMed ID: 33228721
[TBL] [Abstract][Full Text] [Related]
22. A qualitative study to explore daily versus on-demand oral pre-exposure prophylaxis (PrEP) in young people from South Africa, Uganda and Zimbabwe.
Dietrich JJ; Ahmed N; Tshabalala G; Wu M; Mulaudzi M; Hornschuh S; Atujuna M; Muhumuza R; Ssemata AS; Stranix-Chibanda L; Nematadzira T; Bekker LG; Martinson N; Seeley J; Fox J
PLoS One; 2023; 18(6):e0287627. PubMed ID: 37384792
[TBL] [Abstract][Full Text] [Related]
23. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
[TBL] [Abstract][Full Text] [Related]
24. Qualitative characterizations of relationships among South African adolescent girls and young women and male partners: implications for engagement across HIV self-testing and pre-exposure prophylaxis prevention cascades.
Holmes LE; Kaufman MR; Casella A; Mudavanhu M; Mutunga L; Polzer T; Bassett J; Van Rie A; Schwartz S
J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25521. PubMed ID: 32603025
[TBL] [Abstract][Full Text] [Related]
25. Assessing acceptability of pre-exposure prophylaxis (PrEP) among participants in an HIV vaccine preparedness study in southwestern Uganda.
Nakamanya S; Kawuma R; Kibuuka D; Kusemererwa S; McCormack S; Ruzagira E; Seeley J;
PLoS One; 2022; 17(7):e0271104. PubMed ID: 35905052
[TBL] [Abstract][Full Text] [Related]
26. Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa.
van der Straten A; Stadler J; Montgomery E; Hartmann M; Magazi B; Mathebula F; Schwartz K; Laborde N; Soto-Torres L
PLoS One; 2014; 9(2):e89118. PubMed ID: 24586534
[TBL] [Abstract][Full Text] [Related]
27. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study.
Velloza J; Khoza N; Scorgie F; Chitukuta M; Mutero P; Mutiti K; Mangxilana N; Nobula L; Bulterys MA; Atujuna M; Hosek S; Heffron R; Bekker LG; Mgodi N; Chirenje M; Celum C; Delany-Moretlwe S;
J Int AIDS Soc; 2020 Mar; 23(3):e25463. PubMed ID: 32144874
[TBL] [Abstract][Full Text] [Related]
28. Prospective study of oral pre-exposure prophylaxis initiation and adherence among young women in KwaZulu-Natal, South Africa.
Mansoor LE; Lewis L; Naicker CL; Harkoo I; Dawood H; Naidoo K; Gengiah TN; Samsunder N; Beesham I; Abdool Karim SS; Abdool Karim Q
J Int AIDS Soc; 2022 Jul; 25(7):e25957. PubMed ID: 35785472
[TBL] [Abstract][Full Text] [Related]
29. Experiences of oral pre-exposure prophylaxis (PrEP) use disclosure among South African adolescent girls and young women and its perceived impact on adherence.
Giovenco D; Gill K; Fynn L; Duyver M; O'Rourke S; van der Straten A; Morton JF; Celum CL; Bekker LG
PLoS One; 2021; 16(3):e0248307. PubMed ID: 33667264
[TBL] [Abstract][Full Text] [Related]
30. Perceptions of HIV Preexposure Prophylaxis Among Young Pregnant Women from Rural KwaZulu-Natal, South Africa.
Vazquez L; Moll AP; Kacin A; Ndlovu NE; Shenoi SV
AIDS Patient Care STDS; 2019 May; 33(5):214-219. PubMed ID: 31067125
[TBL] [Abstract][Full Text] [Related]
31. Understanding PrEP decision making among pregnant women in Lilongwe, Malawi: A mixed-methods study.
Hill LM; Golin CE; Saidi F; Phanga T; Tseka J; Young A; Pearce LD; Maman S; Chi BH; Mutale W
J Int AIDS Soc; 2022 Sep; 25(9):e26007. PubMed ID: 36074034
[TBL] [Abstract][Full Text] [Related]
32. Factors that influence adolescent girls and young women's re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa.
de Vos L; Mudzingwa EK; Fynn L; Atujuna M; Mugore M; Gandhi M; Celum C; Hosek S; Bekker LG; Daniels J; Medina-Marino A
J Int AIDS Soc; 2023 Sep; 26(9):e26175. PubMed ID: 37758649
[TBL] [Abstract][Full Text] [Related]
33. Barriers to Oral HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Pregnant and Post-partum Women from Cape Town, South Africa.
Beesham I; Dovel K; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
AIDS Behav; 2022 Sep; 26(9):3079-3087. PubMed ID: 35316471
[TBL] [Abstract][Full Text] [Related]
34. Providers' Attitudes and Experiences with Pre-Exposure Prophylaxis Implementation in a Population-Based Study in Kenya and Uganda.
Camlin CS; Getahun M; Koss CA; Owino L; Akatukwasa C; Itiakorit H; Onyango A; Bakanoma R; Atwine F; Maeri I; Ayieko J; Atukunda M; Owaraganise A; Mwangwa F; Sang N; Kabami J; Kaplan RL; Chamie G; Petersen ML; Cohen CR; Bukusi EA; Kamya MR; Havlir DV; Charlebois ED
AIDS Patient Care STDS; 2022 Oct; 36(10):396-404. PubMed ID: 36201226
[TBL] [Abstract][Full Text] [Related]
35. PrEP uptake and delivery setting preferences among clients visiting six healthcare facilities in Eswatini.
Inghels M; Kim HY; Tanser F; Hettema A; McMahon SA; Oldenburg CE; Matse S; Kohler S; Geldsetzer P; Bärnighausen T
AIDS Behav; 2022 Oct; 26(10):3345-3355. PubMed ID: 35429309
[TBL] [Abstract][Full Text] [Related]
36. Rethinking HIV prevention to prepare for oral PrEP implementation for young African women.
Celum CL; Delany-Moretlwe S; McConnell M; van Rooyen H; Bekker LG; Kurth A; Bukusi E; Desmond C; Morton J; Baeten JM
J Int AIDS Soc; 2015; 18(4 Suppl 3):20227. PubMed ID: 26198350
[TBL] [Abstract][Full Text] [Related]
37. Preferences for Long-Acting PrEP Products Among Women and Girls: A Quantitative Survey and Discrete Choice Experiment in Eswatini, Kenya, and South Africa.
Little KM; Hanif H; Anderson SM; Clark MR; Gustafson K; Doncel GF
AIDS Behav; 2024 Mar; 28(3):936-950. PubMed ID: 37971614
[TBL] [Abstract][Full Text] [Related]
38. PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study.
Poteat T; Malik M; van der Merwe LLA; Cloete A; Adams D; Nonyane BAS; Wirtz AL
Lancet HIV; 2020 Dec; 7(12):e825-e834. PubMed ID: 32622370
[TBL] [Abstract][Full Text] [Related]
39. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study.
Mack N; Evens EM; Tolley EE; Brelsford K; Mackenzie C; Milford C; Smit JA; Kimani J
J Int AIDS Soc; 2014; 17(3 Suppl 2):19157. PubMed ID: 25224616
[TBL] [Abstract][Full Text] [Related]
40. Understanding user perspectives of and preferences for oral PrEP for HIV prevention in the context of intervention scale-up: a synthesis of evidence from sub-Saharan Africa.
Eakle R; Weatherburn P; Bourne A
J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25306. PubMed ID: 31328429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
